How to Connect | Boehringer Ingelheim US
How to Connect
Much like an ecosystem, the life sciences community is connected through a collective drive to innovate. Our partnering environment is built on trust and scientific collaboration. We focus on co-creating, accelerating scientific breakthroughs and delivering solutions for patients.
Whether you’re a biotech innovator or academic researcher, let’s start a conversation about partnering!
Our team
We work across the globe reaching partners from North America, Europe, Asia and more. Every member of our team has experience in dedicated disease areas or technology spaces. We’re pursuing new partnerships and evolving current collaborations to broaden our capabilities and explore new therapeutic areas and modalities.
Interested in partnering? Let's connect! Fill out our contact form and share a brief non-confidential project summary with us. We’ll typically respond to you in under seven business days. Please note that this communication is not intended for adverse event reporting.
Find a team member
Cardiovascular-renal-metabolic diseases
| Andrew Whittle, PhD Head of CRM business development Boston, MA (USA) Partnership focus: Kidney diseases and obesity |
| Annika Baur, PhD Biberach, Germany Partnership focus: Liver disease |
| Robert Augustin, PhD Biberach, Germany Partnership focus: Stroke and cardiovascular disease |
Eye health
| Peter Benz, PhD Head of eye health business development Biberach, Germany Partnership focus: Diseases of the back of the eye |
Immunology and respiratory diseases
| Fei Shen, PhD Head of global inflammation business development Boston, MA (USA) Partnership focus: Pulmonary fibrosis, inflammatory bowel disease, systemic lupus erythematosus and rheumatoid arthritis |
| David Blair, PhD Ridgefield, Connecticut (USA) Partnership focus: Immunological disorders |
| Christian Kuttruff, PhD Biberach, Germany Partnership focus: Respiratory diseases (idiopathic pulmonary fibrosis, progressive pulmonary fibrosis) |
| Marcio Lasaro, PhD Ridgefield, Connecticut (USA) Partnership focus: Immunological disorders |
Mental health and neuroscience
| René Fürtig, PhD Head of mental health business development Ingelheim, Germany Partnership focus: Psychiatric disorders, Nociplastic pain |
| Radoslaw Lipinski, DPhil Biberach, Germany Partnership focus: Neurodegeration, Psychiatric disorders |
Oncology
| Oliver Kast, PharmD Head of oncology business development Ingelheim, Germany Partnership focus: Solid tumor therapies, targeted therapeutics, immuno-oncology |
| Stephanie Glaser, PhD Ingelheim, Germany Partnership focus: Antibody drug conjugates, T cell engagers |
| Anto Impagnatiello, PhD Vienna, Austria Partnership focus: Antibody drug conjugates, immunogenic cell death |
| Sokol Haxhinasto, PhD Ridgefield, Connecticut (USA) Partnership focus: Immuno-oncology, T cell engagers |
Emerging science
| Bernd Nosse, PhD Head of emerging areas Biberach, Germany Partnership focus: Adeno-associated virus gene therapies, Neurodegeneration |
Technologies
| Radoslaw Lipinski, DPhil Biberach, Germany Partnership focus: Small molecule technology |
| Marcio Lasaro, PhD Ridgefield, Connecticut (USA) Partnership focus: Antibody technology |
| Gang Wang, PhD Ridgefield, Connecticut (USA) Partnership focus: Antibody technology |
| Christian Kuttruff, PhD Biberach, Germany Partnership focus: Small molecule technology |
| Alessandra Barazza, PhD Ridgefield, Connecticut (USA) Partnership focus: Antibody technology |
Cross-therapeutic area partnering in Asia
| June Hahn, PhD Seoul, Republic of Korea |
Learn more about our partnering interests and other business opportunities across our company.
[Learn more](/content/us/partnering/human-health-partnering/partnering-interests "Partnering interests"/index.html)
Partnering interests
Read about the areas where we’re looking to partner.
[Learn more](/content/us/partnering/human-health-partnering/partnering-interests "Learn more"/index.html)
Independent funding
Explore opportunities with the Boehringer Ingelheim Venture Fund.
[Learn more](/content/us/disclaimer/external?path=https%3A%2F%2Fwww.boehringer-ingelheim-venture.com%2F "Learn more"/index.html)
Beyond partnering
Business development isn’t the only way to make a difference together.
Stay up to date on our most recent partnerships and research collaborations.